NASDAQ: CKPT

Checkpoint Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 4, 2024.

If you purchased Checkpoint securities and would like to join the action, please click “Join This Class Action.”

Class Period:March 10, 2021 through December 15, 2023

Deadline:

7 Days
If you purchased Checkpoint secuirites during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that:

  • Checkpoint had overstated its oversight of, and/or its establishment of adequate manufacturing standards and controls over, its third-party contract manufacturers;
  • accordingly, there were one or more issues with Checkpoint’s third-party contract manufacturing organization (“CMO”) for cosibelimab, Checkpoint’s lead antibody product candidate;
  • all the foregoing reduced the likelihood that the Federal Drug Administration would approve the cosibelimab Biologics License Application (“BLA”) in its present form;
  • as a result, the manufacturing, regulatory, and commercial prospects of cosibelimab were overstated; and
  • as a result, Checkpoint’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Checkpoint Therapeutics, Inc.
Stock Symbol: CKPT
Class Period: March 10, 2021 through December 15, 2023
Court: United States District Court for the Southern District of New York

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top